Leakages in Ampoules cause Recalls

Recommendation
13/14 May 2025
GM Requirements for Planning, Qualification and Operation
Again, there is a recall of sterile ampoules in Switzerland. The manufacturer stated a possible leakage as reason for the recall. The area concerned seems to be the breaking point as was the case in the recall by Streuli Pharma in 2013. This case was presented at the ECA Conference "Particles in Parenterals and beyond" in Copenhagen in September 2014. Product had crystallized on the outer surface of the ampoule at the breaking point. Although the leakage could not be verified with any method available and no contamination of the product came to be known it was not possible to exclude that microorganisms could penetrate into the ampoule. Consequently, non-sterility could not be excluded. According to a statement from Streuli Pharma this packaging material problem could not be solved so that they had to change the primary packaging material within a very short time.
You can find the case which occurred only now but is described in an analogous way at the page of Swissmedic.
Another sterile medicinal product had to be recalled in Switzerland because of crystallization of the product (particle formation) in the solution for injection.
Batches of another product were withdrawn from the market because of possible metal particles already in October.
Related GMP News
12.02.2025The End of the Printed Package leaflet?
05.02.2025New EDQM Guide on Compliance and Safety of Food Contact Materials
23.01.2025EU Ban of BPA and other Bisphenols in Food Contact Materials
11.12.2024New Ph. Eur. Chapters on COC, COP and SBC approved
13.11.2024Revised USP Chapter <383> Cured Silicone Elastomers
09.10.2024GMP Requirements for Ready to Sterilize (RTS) and Ready to Use (RTU) Containers